Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Ophthalmologicals

Vislyfa

(ranibizumab)

Uses, side effects, dosage information & price range

Lupin Europe GmbH

About this medicine

Treatment of adults with of neovascular (wet) age-related macular degeneration (AMD), visual impairment and other retinopathies

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

LucentisComposition: ranibizumabNovartis Europharm Limited

Price on RequestView Details →

RanluspecComposition: ranibizumabLupin Europe GmbH

Price on RequestView Details →

RexatiluxComposition: ranibizumabIntas Third Party Sales 2005 S.L.

Price on RequestView Details →

ByoovizComposition: ranibizumabSamsung Bioepis NL B.V.

Price on RequestView Details →

RimmyrahComposition: ranibizumabQilu Pharma Spain S.L.

Price on RequestView Details →

Key Information

Salt / Composition

ranibizumab

Category

Ophthalmologicals

Manufacturer

Lupin Europe GmbH

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.